Triad of trichomegaly, alopecia and male-pattern hair growth during treatment with erlotinib in non-small-cell lung cancer.
Description of the cutaneous side effects of erlotinib. Report with images of a single case. Case report and review of the literature. Erlotinib is associated with significant cutaneous toxicity which should be recognised and managed appropriately.